Uptake and 24-month outcomes of dolutegravir- versus lopinavir-based second-line antiretroviral therapy for people with HIV in South Africa: a retrospective cohort study and emulated target trial
Brown JA., Lewis L., Sookrajh Y., Hobe L., Ngwenya T., van der Molen J., Asare K., Tlhaku K., Khanyile M., Khubone T., Bottomley C., Garrett N., Dorward J.